Early-stage clinical data with CanSino Biologics' inhaled COVID-19 vaccine show that it was able to stimulate neutralising antibodies against SARS-CoV-2 at a dose well below that required with ...

In 2021, Tianjin-based biopharmaceutical company, CanSino Biologics (CanSinoBIO) completed a Phase III clinical trial of their intramuscular COVID-19 vaccine, which involved 45,000 volunteers ...

Pierre A. Morgon, PharmD, LL.M, MBA, managing director at CanSino Biologics Europe, tells us about Convidecia, a single dose SARS-CoV-2 vaccine offered as an injectable and inhalant that allows ...

SHANGHAI--China’s CanSino Biologics Inc. said on Wednesday that expert opinion on its high-profile coronavirus vaccine candidate should not be followed “blindly” without sufficient clinical ...

The Geneva-based World Health Organization (WHO) Thursday granted an emergency approval to the CONVIDECIA vaccine against COVID-19 developed by China's CanSino Biologics. The drug thus became the ...

BEIJING--China’s vaccine specialist CanSino Biologics Inc. has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the ...

The restriction came as Pakistan recorded more than 4,000 cases for a third straight day on Sunday, according to the data issued by the ministry of National Health Services. Advisory Alert: It has ...

KOTA BARU: The government will be supplying the CanSino vaccine to Kelantan in July to inoculate people living in the interior including Orang Asli. National Covid-19 Immunisation Programme ...

The Tianjin, China-based company, which was the first to move a vaccine into Phase II development, also became the first to published peer-reviewed data, from its Phase I study. Moderna released ...

KOTA KINABALU: Sabah has begun administering the single-dose CanSino Covid-19 vaccine, with about 650 villagers from Pulau Mantanani among the first to receive it in the state. Pintasan ...